Chairman + CEO
Anthony P. Mack is an entrepreneur who has founded three successful pharmaceutical companies, served on executive boards and has more than 35 years of experience in the industry including 10 years in finance. Prior to founding and taking Virpax Pharmaceuticals public (Nasdaq: VRPX), Mr. Mack founded Scilex Pharmaceuticals (Nasdaq: SCLX) and served as President, CEO and Director until February 2018. Scilex was sold to a publicly traded company. Mr. Mack founded his first pharmaceutical company, ProSolus Pharmaceuticals, in 2009 where he served as President and Director before selling the company to Mission Pharmacal in 2015. As a key executive in the pharmaceutical industry, Mr. Mack has overseen global strategies to advance business development, product development, market research, regulatory positioning, marketing and commercialization. Prior to his pharmaceutical career, Mr. Mack worked in the financial sector, starting as a Series 7 broker dealer then a Series 24 licensed Principal, allowing him to supervise and manage brokers at affiliated branches. Mr. Mack holds an Executive MBA in Pharmaceutical and Healthcare Marketing from Saint Joseph’s University.